Loading clinical trials...

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

NCT03503240•Memorial Sloan Kettering Cancer Center

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate patient satisfaction and quality of life as it relates to skin cancer surgery. This research study involves taking a one-time survey online.

Eligibility

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients ≥ 18 years of age at the time of surgery.
•Had a diagnosis of a cutaneous malignancy
•* Cutaneous malignancy includes, but is not limited to basal cell carcinoma, squamous cell carcinoma, and melanoma
•Able to speak and read English
•MSK Only Cross Sectional Study: Radiation therapy patients ≥ 18 years of age who have received RT for skin cancer

Exclusion Criteria

•Unable to speak and read English

Locations (5)

UC Davis Comprehensive Cancer Center

Sacramento, California, United States

Brigham and Women's Hospital (Data Collection Only)

Boston, Massachusetts, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

University of Texas Southwestern Medical Center at Dallas

Dallas, Texas, United States

Key Dates

Start Date

April 6, 2018

Primary Completion Date

April 1, 2026

Completion Date

April 1, 2026

Last Updated

January 2, 2026

Enrollment

3,000

ESTIMATED participants

Conditions

Skin Cancer

Pilot Trial of Supplemental Vitamin A and Nicotinamide

NCT05702398

Skin CancerKidney Transplant Recipients

View study

RECRUITING

Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker

NCT07266142

Skin Cancer, Non-MelanomaSkin Cancer Melanoma

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 2, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery

Inclusion Criteria

Exclusion Criteria

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Tranexamic Acid in Nasal Mohs Reconstruction